- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02694471
Effect of 14 Day Bed Rest on Health Outcomes in Young and Older Participants (BEDREST)
CB147 - Physical Activity and Nutrition for Quality Ageing
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Twenty-three healthy men, of which 7 young (YM; aged 18-30 years) and 16 older adults (OM; aged 55-65 years) were recruited for the study. All participants underwent medical examination and routine blood and urine analysis. Exclusion criteria were: smoking; regular alcohol consumption; ferromagnetic implants; history of deep vein thrombosis with D-dimer > 500 μg·L-1; acute or chronic skeletal, neuromuscular, metabolic and cardiovascular disease conditions; pulmonary embolism. Participants were informed of the purpose, procedures and potential risk of the study before signing the informed consent. The study was performed in accordance with the ethical standards of the 1964 Declaration of Helsinki and was approved by the National Ethical Committee of the Slovenian Ministry of Health on April 17, 2012.
The study was conducted in controlled medical environment of the Orthopedic Hospital of Valdoltra, Slovenia. The participants were housed in standard air conditioned hospital rooms and were under constant surveillance with 24-hour medical care. For 14 days, the participants performed all daily activities in bed and received eucaloric controlled meals three times a day. Dietary energy requirements were designed for each subject multiplying resting energy expenditure by factors 1.2 and 1.4 in BR and ambulatory period, respectively. The resting energy expenditure was calculated as done in previous studies. The macronutrient food content set at 60% of carbohydrates, 25% fat, and 15% of proteins, according to the scheme of the so called "mediterranean diet" and adopted also in previous bed rest protocols. Energy balance was checked weekly by fat mass assessment. The daily protein intake was 1.1-1.25 g kg-1 in both groups, in BR and recovery period respectively, except the subgroups of OM who received a supplementation (see below).
After the BR, participants underwent a rehabilitation protocol (R) that consisted of 4-week supervised multimodal exercise program with 3 sessions per week. In each session, participants performed 12-minute warm-up, 15-20 minutes of balance and strength training, and 20-30 minutes of endurance training.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Ankaran, Slovenia, 6280
- Orthopaedic Hospital Valdoltra
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Body mass index < 28 kg/m2
- Short physical performance battery score >= 9
Exclusion Criteria:
- smoking;
- regular alcohol consumption;
- ferromagnetic implants;
- history of deep vein thrombosis with D-dimer > 500 μg·L-1;
- acute or chronic skeletal, neuromuscular, metabolic and cardiovascular disease conditions.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Old group
16 old participants (55-65 years) were included in physical inactivity or bed rest with supervised recovery intervent and underwent 14-day of bed rest.
Bed rest was followed by 28-day recovery.
During the bed rest participants will remain 24-hour horizontal with all daily activities performed lying in a bed.
No social isolation will be forced.
During the recovery participants will 3-times weekly per 75 minutes perform guided exercises to achieve baseline level.
|
All (older and younger) participants underwent 14 day of horizontal bed rest with all 24 hour daily activities were performed lying in a bed.
Maximal one pillow was allowed.
28-day supervised recovery was performed 3 times weekly for 75 minutes/session.
|
|
Active Comparator: Young group
7 young participants (18-30 years) were included in physical inactivity or bed rest with supervised recovery intervent and underwent 14-day of bed rest.
Bed rest was followed by 28-day recovery.
During the bed rest participants will remain 24-hour horizontal with all daily activities performed lying in a bed.
No social isolation will be forced.
During the recovery participants will 3-times weekly per 75 minutes perform guided exercises to achieve baseline level.
|
All (older and younger) participants underwent 14 day of horizontal bed rest with all 24 hour daily activities were performed lying in a bed.
Maximal one pillow was allowed.
28-day supervised recovery was performed 3 times weekly for 75 minutes/session.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in quadriceps muscle volume (young vs. old) after 14-day bed rest
Time Frame: At baseline and after 14-day bed rest and on 14th day of recovery
|
Using MRI continous screening of single leg was performed
|
At baseline and after 14-day bed rest and on 14th day of recovery
|
|
Change in diameter of single fibre contractions (young vs. old) after 14-day bed rest
Time Frame: baseline and after 14-day bed rest and on 14th day of recovery
|
Biopsy samples were obtained from vastus lateralis muscles
|
baseline and after 14-day bed rest and on 14th day of recovery
|
|
Change in peak aerobic power (VO2max) (young vs. old) after 14-day bed rest
Time Frame: baseline and after 14-day bed rest and on 14th day of recovery
|
graded cycling on sitting ergometer until exhaustion
|
baseline and after 14-day bed rest and on 14th day of recovery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in peak knee extensor force (young vs. old) after 14-day bed rest
Time Frame: baseline and after 14-day bed rest and on 14th day of recovery
|
Estimated from single leg isometric maximal voluntary contraction
|
baseline and after 14-day bed rest and on 14th day of recovery
|
|
Change in lower limb explosive power (young vs. old) after 14-day bed rest
Time Frame: baseline and after 14-day bed rest and on 14th day of recovery
|
estimated from bilateral efforts on explosive ergometer (EXER)
|
baseline and after 14-day bed rest and on 14th day of recovery
|
|
Change in gait stride length (young vs. old) after 14-day bed rest
Time Frame: baseline and after 14-day bed rest and on 14th and 400th day of recovery
|
Walking through the food placement detection system
|
baseline and after 14-day bed rest and on 14th and 400th day of recovery
|
|
Change in insulin sensitivity (young vs. old) after 14-day bed rest
Time Frame: baseline and after 14-day bed rest and on 14th day of recovery
|
collected hourly for 6 hours after standard meal load as a measure of insulin sensitivity index
|
baseline and after 14-day bed rest and on 14th day of recovery
|
|
Change in area-under-the curve (AUC) of triglycerides plasma concentration (young vs. old) after 14-day bed rest
Time Frame: baseline and after 14-day bed rest and on 14th day of recovery
|
collected hourly for 3 hours after standard meal load
|
baseline and after 14-day bed rest and on 14th day of recovery
|
|
Change in N-telopeptide (young vs. old) after 14-day bed rest
Time Frame: baseline, during and after 14-day bed rest and during first 14 day of recovery
|
From urine collection
|
baseline, during and after 14-day bed rest and during first 14 day of recovery
|
|
Change in C-telopeptide (young vs. old) after 14-day bed rest
Time Frame: baseline, during and after 14-day bed rest and during first 14 day of recovery
|
From urine collection
|
baseline, during and after 14-day bed rest and during first 14 day of recovery
|
|
Change is contraction time (young vs. old) after 14-day bed rest
Time Frame: baseline and after 14-day bed rest and on 14th day of recovery
|
From Tensiomyographic response in vastus lateralis
|
baseline and after 14-day bed rest and on 14th day of recovery
|
|
Change in force of single muscle fibre contraction (young vs. old) after 14-day bed rest
Time Frame: baseline and after 14-day bed rest and on 14th day of recovery
|
Biopsy samples were obtained from vastus lateralis muscles
|
baseline and after 14-day bed rest and on 14th day of recovery
|
|
Change in specific force of single muscle fibre contraction (young vs. old) after 14-day bed rest
Time Frame: baseline and after 14-day bed rest and on 14th day of recovery
|
Biopsy samples were obtained from vastus lateralis muscles
|
baseline and after 14-day bed rest and on 14th day of recovery
|
|
Change in velocity of single muscle fibre contraction (young vs. old) after 14-day bed rest
Time Frame: baseline and after 14-day bed rest and on 14th day of recovery
|
Biopsy samples were obtained from vastus lateralis muscles
|
baseline and after 14-day bed rest and on 14th day of recovery
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Rado Pišot, PhD, University of Primorska, Slovenia
Publications and helpful links
General Publications
- Pisot R, Marusic U, Biolo G, Mazzucco S, Lazzer S, Grassi B, Reggiani C, Toniolo L, di Prampero PE, Passaro A, Narici M, Mohammed S, Rittweger J, Gasparini M, Gabrijelcic Blenkus M, Simunic B. Greater loss in muscle mass and function but smaller metabolic alterations in older compared with younger men following 2 wk of bed rest and recovery. J Appl Physiol (1985). 2016 Apr 15;120(8):922-9. doi: 10.1152/japplphysiol.00858.2015. Epub 2016 Jan 28.
- Jurdana M, Jenko-Praznikar Z, Mohorko N, Petelin A, Jakus T, Simunic B, Pisot R. Impact of 14-day bed rest on serum adipokines and low-grade inflammation in younger and older adults. Age (Dordr). 2015 Dec;37(6):116. doi: 10.1007/s11357-015-9848-z. Epub 2015 Nov 13.
- Marusic U, Kavcic V, Giordani B, Gerzevic M, Meeusen R, Pisot R. Computerized spatial navigation training during 14 days of bed rest in healthy older adult men: Effect on gait performance. Psychol Aging. 2015 Jun;30(2):334-340. doi: 10.1037/pag0000021. Epub 2015 May 4.
- Goswami N, Kavcic V, Marusic U, Simunic B, Rossler A, Hinghofer-Szalkay H, Pisot R. Effect of computerized cognitive training with virtual spatial navigation task during bed rest immobilization and recovery on vascular function: a pilot study. Clin Interv Aging. 2015 Feb 10;10:453-9. doi: 10.2147/CIA.S76028. eCollection 2015.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PANGEA
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Muscular Atrophy
-
St Mary's University CollegeNot yet recruitingAtrophy, Muscular | Atrophy, Disuse
-
United States Army Research Institute of Environmental...CompletedMuscular Disorders, Atrophic | Muscle Atrophy | Disuse Atrophy | Atrophy, Disuse | Disuse Atrophy Muscle of ThighUnited States
-
Marco CapogrossoRoche-GenentechActive, not recruitingSpinal Muscular Atrophy | Spinal Muscular Atrophy Type 3 | SMA | Spinal Muscular Atrophy Type II | Spinal Muscular Atrophy 4United States
-
Hoffmann-La RocheActive, not recruitingSpinal Muscular Atrophy (SMA)United States, Spain, Canada, United Kingdom, Croatia, Australia, Netherlands, Japan, Poland, Belgium, Portugal, Italy
-
Institut de Myologie, FranceInstitut RocheCompletedType 2 Spinal Muscular Atrophy | Type 3 Spinal Muscular AtrophyBelgium, France, Germany
-
McMaster UniversityTerminatedSarcopenia | Muscle Atrophy | Muscle Disuse AtrophyCanada
-
South Dakota State UniversitySanford ResearchCompletedDisuse AtrophyUnited States
-
McGill UniversityCompletedMuscle Atrophy | Muscle Disuse AtrophyCanada
-
BiogenNo longer availableInfantile-onset Spinal Muscular AtrophyNew Zealand, Colombia, Turkey (Türkiye)
-
Marco CapogrossoRoche-GenentechCompletedSpinal Muscular Atrophy Type 3 | Spinal Muscular Atrophy Type 4United States
Clinical Trials on physical inactivity or bed rest with supervised recovery
-
Science and Research Centre KoperUniversity of Trieste; University of Padova; University of Pavia; University of... and other collaboratorsCompletedMuscular AtrophySlovenia
-
AO Clinical Investigation and Publishing DocumentationTerminatedSingle Level Stable Thoracolumbar Fracture Type AO A3 | Multiple Level Stable Thoracolumbar Fracture Type AO A3Brazil, Germany, Chile, Czechia, Italy, Portugal
-
University Hospital, GenevaCompletedKeratitis; Infectious Disease (Manifestation)Switzerland
-
Hospital Universitari de BellvitgeInstitut d'Investigació Biomèdica de Bellvitge; University of Barcelona; Hospital...Not yet recruitingObesity | Atypical Endometrial Hyperplasia | Endometrial Cancer | Endometrial Cancer Stage I | Obesity & Overweight | Endometrial Intraepithelial Neoplasia | Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I | BMI>40 | Obesity Grade III